ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

NCT04620239 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Transitional Cell Cancer of Renal Pelvis and Ureter

Interventions

DRUG: padeliporfin VTP

Sponsor

Steba Biotech S.A.

Collaborators

[object Object]
[object Object]